The independent specialty practice, in 2026.

The story of American specialty medicine since roughly 2010 has been a story of consolidation. Hospital systems acquired physician groups. Private equity assembled regional platforms. Payers bought care-delivery assets. The share of physicians in independent practice fell, decade over decade, across almost every specialty.¹

The conventional explanation was that the independent practice simply could not carry the administrative and capital costs of modern medicine. Prior authorization volume, coding complexity, quality reporting, technology investment — the overhead had grown past what a 6-, 8-, or 12-physician group could reasonably absorb. Scale was the answer. The question was only which kind of scale.

That story was true. It is not as true in 2026 as it was in 2019.

What changed

Three shifts, running on different clocks, have combined to move the arithmetic.

The consolidation backlash

The private-equity rollup model that powered a large share of specialty consolidation in the 2015–2022 window has, by 2026, run into most of its predictable problems: physician dissatisfaction at post-acquisition practices, operational integration that failed to deliver promised efficiencies, debt-service pressure in a higher-rate environment, and a wave of exits and restructurings at the platform level.²

Hospital employment has its own headwinds. The growth in hospital-employed physicians, which was the dominant trend of the previous decade, has slowed markedly. Some of the largest systems have begun divesting practice groups. The implicit promise — that hospital employment would trade autonomy for stability — has not held up evenly across specialties.

Neither of these shifts means the independent practice has won. They mean the available alternatives are less obviously attractive than they were five years ago. That alone changes the calculation.

The administrative cost curve

Administrative expense per clinician has been the single biggest economic argument against independent practice. American medicine spends an estimated $1 trillion annually on administration — roughly a quarter of total spending — and the per-clinician share of that burden falls disproportionately on smaller groups.³

The emergence of AI workforces — and, frankly, the competitive pressure that has forced them to be genuinely priced for a 6-physician group rather than a 600-physician system — is beginning to compress that cost curve. A specialty practice in 2026 can access prior authorization automation, ambient documentation, and coding augmentation at price points that did not exist for it in 2019.

This is not a theoretical observation. It is visible in the per-physician revenue-cycle and administrative cost lines of the practices already piloting these tools. The savings are not large enough, yet, to flip the consolidation calculus on their own. They are large enough to be part of a credible argument for staying independent.

The regulatory direction

The third shift, often underrated, is regulatory. Rules that would have been crushing for a small independent practice five years ago are, in many cases, the shape of rules that make the modernized independent practice more viable in 2026 — because they are rules about standardized, machine-readable interfaces.

• CMS-0057-F — the prior authorization interoperability rule that took effect in January 2026 — forces impacted payers to expose machine-readable APIs for prior authorization. That API surface is exactly the kind of thing a software system can leverage; it favors practices that have automation, not practices that have large manual back offices.
• ONC interoperability rules continue to mandate standardized data access across EHR vendors. This reduces the historical advantage of being inside a large integrated system, where “integration” was purchased by being absorbed.
• The 2025 HIPAA Security Rule update has raised the compliance floor for everyone, large and small. Small practices working with serious HIPAA-compliant AI vendors can now meet that floor without building an internal security team.

The pattern is worth naming: the regulatory direction is toward standardized interfaces, and standardized interfaces are the friend of the small, well-automated practice.

What the 2026 independent practice looks like

The independent specialty practice that is doing well in 2026 is not, as a rule, the practice that has stayed the same for fifteen years. It is a different kind of organization from the independent practice of 2015.

A few characteristics recur:

What the numbers look like

The economic argument for the modernized independent specialty practice runs, roughly, like this:

• Top line — physician compensation in an independent group, for reasonable call and productivity, tends to run 15–30% above hospital-employed comparators in most specialties, once ancillary income is included. This has been true for years; it remains true.⁶
• Administrative cost — this has historically been the argument against independence. In 2026, the gap between an independent group’s per-physician admin spend and a hospital’s allocated per-physician admin spend is narrowing for groups that have adopted serious automation.
• Capital cost — the PE rollup model required the practice to sell a large share of its future cash flows at a multiple. The modernized independent group generally does not take this haircut; over a 10-year horizon, the value retention is material.
• Optionality — the independent practice retains the option to sell later, to join a value-based contract, to add a line of service, to exit a line of service. The consolidated practice has, by definition, already exercised many of those options.

None of this makes independence the right answer for every practice. It does not address the genuine reasons some practices consolidate — succession planning in a small group, capital requirements for an ambitious service-line build, or the simple preference of individual physicians for salaried life. Those reasons remain valid and will keep a steady share of the specialty workforce moving into employed or PE-backed settings.

What the 2026 picture does argue is that the wholesale assumption — that the independent specialty practice is structurally non-viable and that consolidation is the only serious option — is no longer correct. For a practice with the right temperament, the right specialty, and a willingness to modernize, staying independent is an economically defensible choice in a way it was not five years ago.

What has to be true for the economics to hold

Three conditions. None of them are optional.

The administrative stack has to actually modernize. An independent practice running a 2015 back office with 2026 rates of reimbursement and payer complexity will not survive. The economics are premised on compression of the administrative cost line, and that compression does not happen on its own.

The partner group has to be aligned on long-term independence. Drift toward sale — “let’s just take the offer and get out” — is the proximate cause of most consolidations, not the underlying economics. A group that is divided on direction will find a way to consolidate.

The group has to have a plan for the next generation. Succession is where independence most often fails. A group that cannot attract and retain young physicians — usually a question of lifestyle, compensation structure, and the physician experience of the job, not economics — will sell within a decade regardless of balance-sheet strength.

The frame

The question of whether to remain independent, or to consolidate, has historically been framed as a question about scale. In 2026, it is better framed as a question about what kind of scale. The modernized independent specialty practice operates at the scale of its own patient panel — but with an administrative stack that runs at a much larger scale, because the AI workforce it employs is effectively shared infrastructure.

For a fifteen-year window after roughly 2008, the most economically rational path for a specialty physician was to accept one of the consolidation pathways. The arithmetic said so, and the arithmetic was correct.

Three shifts have moved the arithmetic. Whether any individual practice should respond to that movement is a question of temperament, specialty, and local market — not a matter of economic inevitability. But the inevitability itself is no longer the story.